Mark Thorpe - Jan 16, 2022 Form 3 Insider Report for Eargo, Inc. (EAR)

Signature
/s/ Adam Laponis, Attorney-in-Fact for Mark Thorpe
Stock symbol
EAR
Transactions as of
Jan 16, 2022
Transactions value $
$0
Form type
3
Date filed
1/26/2022, 04:05 PM
Next filing
Aug 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EAR Common Stock 19.3K Jan 16, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EAR Stock Option (Right to Buy) Jan 16, 2022 Common Stock 34K $2.55 Direct F2
holding EAR Stock Option (Right to Buy) Jan 16, 2022 Common Stock 42K $2.55 Direct F3
holding EAR Stock Option (Right to Buy) Jan 16, 2022 Common Stock 16.7K $5.73 Direct F4
holding EAR Stock Option (Right to Buy) Jan 16, 2022 Common Stock 16.7K $5.73 Direct F5
holding EAR Stock Option (Right to Buy) Jan 16, 2022 Common Stock 2.04K $51.33 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes Restricted Stock Units ("RSUs") which vest in 16 quarterly installments commencing on February 15, 2021, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date. Each RSU represents a contingent right to receive one (1) share of common stock of the Issuer.
F2 The stock option shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject to the stock option on the first anniversary of September, 2019 (the "Vesting Start Date") and one forty-eighth (1/48th) of the shares of subject to the option shall vest and become exercisable on each monthly anniversary thereafter until all of the shares subject to the stock option have vested and become exercisable on the fourth anniversary of the Vesting Start Date, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date.
F3 The stock option shall vest and become exercisable with respect to one forty-eighth (1/48th) of the shares subject to the stock option on the one month anniversary of August 3, 2020 (the "Vesting Start Date") and one forty-eighth (1/48th) of the shares of subject to the option shall vest and become exercisable on each monthly anniversary thereafter until all of the shares subject to the stock option have vested and become exercisable on the fourth anniversary of the Vesting Start Date, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date.
F4 The stock option shall vest and become exercisable with respect to one forty-eighth (1/48th) of the shares subject to the stock option on the one month anniversary of September 18, 2020 (the "Vesting Start Date") and one forty-eighth (1/48th) of the shares of subject to the option shall vest and become exercisable on each monthly anniversary thereafter until all of the shares subject to the stock option have vested and become exercisable on the fourth anniversary of the Vesting Start Date, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date.
F5 The stock option shall vest and become exercisable with respect to one forty-eighth (1/48th) of the shares subject to the stock option on the one month anniversary of October 20, 2020 (the "Vesting Start Date") and one forty-eighth (1/48th) of the shares of subject to the option shall vest and become exercisable on each monthly anniversary thereafter until all of the shares subject to the stock option have vested and become exercisable on the fourth anniversary of the Vesting Start Date, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date.
F6 The stock option shall vest and become exercisable in 16 quarterly installments commencing on February 15, 2021 (the "Vesting Start Date") until all of the shares subject to the stock option have vested and become exercisable on the fourth anniversary of the Vesting Start Date, so long as the Reporting Person remains an employee, consultant, director or officer of the Issuer through each such date.